179 related articles for article (PubMed ID: 19597826)
1. Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.
He Y; Mou Z; Li W; Liu B; Fu T; Zhao S; Xiang D; Wu Y
Int J Colorectal Dis; 2009 Nov; 24(11):1271-9. PubMed ID: 19597826
[TBL] [Abstract][Full Text] [Related]
2. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
3. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
[TBL] [Abstract][Full Text] [Related]
4. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
Le Naour F; Misek DE; Krause MC; Deneux L; Giordano TJ; Scholl S; Hanash SM
Clin Cancer Res; 2001 Nov; 7(11):3328-35. PubMed ID: 11705844
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
[TBL] [Abstract][Full Text] [Related]
6. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer.
He Y; Wu Y; Mou Z; Li W; Zou L; Fu T; Zhang A; Xiang D; Xiao H; Wang X
Proteomics Clin Appl; 2007 Mar; 1(3):336-42. PubMed ID: 21136683
[TBL] [Abstract][Full Text] [Related]
8. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer.
Zhou L; Xia D; Zhu J; Chen Y; Chen G; Mo R; Zeng Y; Dai Q; He H; Liang Y; Jiang F; Zhong W
Clin Transl Oncol; 2014 Oct; 16(10):906-13. PubMed ID: 24659377
[TBL] [Abstract][Full Text] [Related]
10. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
12. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.
Liu W; Ma Y; Huang L; Peng J; Zhang P; Zhang H; Chen J; Qin H
Mol Biol Rep; 2010 Oct; 37(7):3207-16. PubMed ID: 19842058
[TBL] [Abstract][Full Text] [Related]
13. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against inosine-5'-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection.
Seelig HP; Appelhans H; Bauer O; Blüthner M; Hartung K; Schranz P; Schultze D; Seelig CA; Volkmann M
Clin Lab; 2011; 57(9-10):753-65. PubMed ID: 22029192
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
[TBL] [Abstract][Full Text] [Related]
16. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
[TBL] [Abstract][Full Text] [Related]
18. Identification of tumor-associated antigens using proteomics.
Naour FL; Brichory F; Beretta L; Hanash SM
Technol Cancer Res Treat; 2002 Aug; 1(4):257-62. PubMed ID: 12625784
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteomics to identify tumor-associated antigens eliciting humoral response.
Mou Z; He Y; Wu Y
Cancer Lett; 2009 Jun; 278(2):123-129. PubMed ID: 18930343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]